Literature DB >> 33510984

Gastrointestinal Histoplasmosis as an Obstructing Ileocecal Mass.

Zaid Nawaz1, Shabiah Martin2, Ari R Reichstein2.   

Abstract

Histoplasmosis is a self-limiting and asymptomatic disease in immunocompetent individuals. Patients in an immunocompromised state are susceptible to disseminated disease. We present a case of a 60-year-old male with a history of psoriatic and rheumatoid arthritis treated with a tumor necrosis factor inhibitor (adalimumab), who presented with abdominal pain and was found to have gastrointestinal histoplasmosis as an obstructing ileocecal mass. Although gastrointestinal involvement is common in disseminating disease, symptomatic involvement is rare. This case presentation has implications in rheumatological patients on biologic medications.
Copyright © 2020, Nawaz et al.

Entities:  

Keywords:  biologic agents; disseminated histoplasmosis; gastrointestinal histoplasmosis; ileocecal mass; small bowel obstruction; tumor necrosis factor inhibitor medications

Year:  2020        PMID: 33510984      PMCID: PMC7828645          DOI: 10.7759/cureus.12277

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

1.  Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.

Authors:  Jong-Hoon Lee; Nancy R Slifman; Sharon K Gershon; Evelyne T Edwards; William D Schwieterman; Jeffrey N Siegel; Robert P Wise; S Lori Brown; John N Udall; M Miles Braun
Journal:  Arthritis Rheum       Date:  2002-10

2.  The pathologic spectrum of gastrointestinal and hepatic histoplasmosis.

Authors:  L W Lamps; C P Molina; A B West; R C Haggitt; M A Scott
Journal:  Am J Clin Pathol       Date:  2000-01       Impact factor: 2.493

3.  Histoplasmosis of the small bowel in patients with AIDS.

Authors:  M A Gumbs; H Girishkumar; A Yousuf; L Levy; M Patel; V Narasimha
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

4.  Colonic histoplasmosis: a difficult diagnostic problem.

Authors:  Georgios Psarros; Carol A Kauffman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

5.  Half-life of methotrexate: new evidence.

Authors:  D H Huffman; S H Wan; D L Azarnoff; K M Halprin
Journal:  Arch Dermatol       Date:  1972-05

Review 6.  Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy.

Authors:  Jeannina A Smith; Carol A Kauffman
Journal:  Drugs       Date:  2009-07-30       Impact factor: 9.546

7.  Disseminated histoplasmosis in patients receiving low-dose methotrexate therapy for psoriasis.

Authors:  L A Witty; F Steiner; M Curfman; D Webb; L J Wheat
Journal:  Arch Dermatol       Date:  1992-01

8.  Gastrointestinal Histoplasmosis Presenting as an Acute Abdomen with Jejunal Perforation.

Authors:  Bryan R Anderson; Jaron Marriott; Chinthaka Bulathsinghala; Humayun Anjum; Salim Surani
Journal:  Case Rep Med       Date:  2018-01-08

9.  A Case of Isolated Gastrointestinal Histoplasmosis.

Authors:  Jasmine Bhinder; Amit Mori; Wenqing Cao; Anju Malieckal
Journal:  Cureus       Date:  2018-07-09

10.  Disseminated histoplasmosis.

Authors:  C A Mansoor; P V Bhargavan; R Rajanish; Lekha R Nair
Journal:  Indian J Orthop       Date:  2013-11       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.